|
NCAPG2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.54770000043914E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.135100E-03 |
| Normal-vs-Stage2 |
1.218750E-01 |
| Normal-vs-Stage3 |
1.278650E-03 |
| Normal-vs-Stage4 |
2.684000E-02 |
| Stage1-vs-Stage2 |
5.226200E-01 |
| Stage1-vs-Stage3 |
2.882400E-02 |
| Stage1-vs-Stage4 |
8.440100E-02 |
| Stage2-vs-Stage3 |
3.481600E-01 |
| Stage2-vs-Stage4 |
5.422200E-01 |
| Stage3-vs-Stage4 |
8.805600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.04460000005524E-06 |
| Normal-vs-AfricanAmerican |
1.537800E-02 |
| Normal-vs-Asian |
2.826800E-01 |
| Caucasian-vs-AfricanAmerican |
1.422220E-01 |
| Caucasian-vs-Asian |
7.470600E-01 |
| AfricanAmerican-vs-Asian |
8.903600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.033530E-04 |
| Normal-vs-Female |
1.20699999994756E-06 |
| Male-vs-Female |
1.093540E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.244500E-02 |
| Normal-vs-Extreme_Weight |
1.012170E-02 |
| Normal-vs-Obese |
7.77790000000556E-05 |
| Normal-vs-Extreme_Obese |
9.762400E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.115200E-01 |
| Normal_Weight-vs-Obese |
1.686440E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.357400E-01 |
| Extreme_Weight-vs-Obese |
8.898200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.856600E-01 |
| Obese-vs-Extreme_Obese |
6.713600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.575100E-03 |
| Normal-vs-Age(41-60Yrs) |
7.7488000005399E-07 |
| Normal-vs-Age(61-80Yrs) |
3.538600E-03 |
| Normal-vs-Age(81-100Yrs) |
2.847000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.013900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.561000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.162300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.033700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.760800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.042000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.37529999999042E-05 |
| Normal-VS-Type2 PRCC |
5.118100E-02 |
| Normal-VS-KIRP CIMP |
6.362000E-03 |
| Normal-VS-Unclassified PRCC |
2.924100E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.366400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.274300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.306200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.528250E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.062300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.462700E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.211440E-01 |
| Normal-vs-N1 |
4.238400E-04 |
| Normal-vs-N2 |
2.083000E-01 |
| N0-vs-N1 |
2.980100E-03 |
| N0-vs-N2 |
8.169700E-02 |
| N1-vs-N2 |
7.555200E-01 |
|
|
